EATG » Access

Access

How patents, data exclusivity and SPCs interact to extend market exclusivity of medicines: the example of Truvada

Patents usually confer 20-year exclusive rights on inventions. Data exclusivity laws confer, depending on the country, 5 to 10 years’ exclusive rights over safety and efficacy data submitted for the…

Belgium and the Netherlands achieve first successful joint drug price

Beneluxa Initiative partners Belgium and the Netherlands successfully negotiated the price of Spinraza Belgium and the Netherlands have reached an agreement on the pricing of Spinraza, a drug for Spinal…

Activists call on Johnson & Johnson to drop the price of bedaquiline

Activists ask the company to drop the price of bedaquiline in all markets to $32 a month or lower. South Africa’s Department of Health recently announced that it will replace…

Finns buying HIV prevention drugs from Germany because they’re cheaper

Some Finnish users of PrEP, an HIV prevention drug, get the antiretroviral from Germany because it's not subsidised - and thus much more expensive - in Finland. With a monthly…

Everyday racism hinders Indigenous women with HIV from accessing care: study

Indigenous women living with HIV experience everyday incidents of racism that impede their access to care disproportionately to other groups, according to a study involving more than 1,400 women across…

South Africa makes bedaquiline part of its standard recommended treatment regimen for rifampicin-resistant TB

Global TB CAB welcomes introduction of safer drug for most South Africans with rifampicin-resistant TB; Other countries and the World Health Organization must now follow. 19 June 2018 -- The…

Treatment Action Group welcomes price reductions for TB medicines

Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required. NEW YORK, NY – June 19, 2018 – Treatment…

Over 300,000 people waiting for hepatitis C treatment in the United States

At least 300,000 people were awaiting treatment for hepatitis C by the end of 2016 in the United States, with the lowest rates of treatment observed in the Upper Midwest,…

MSF challenges Gilead’s unmerited patent in China for lifesaving hepatitis C medicine

Affordable generic versions from China could save millions of people’s lives Geneva/New York, 19 June 2018 - The international medical humanitarian organisation Médecins Sans Frontières (MSF) today filed a legal…

Bringing HIV services closer to people in Osh, Kyrgyzstan

Absamov Mannap Kamilovich works as a peer consultant in a primary health-care clinic in the city of Osh, in southern Kyrgyzstan. Mr Absamov injected drugs for more than 20 years,…

1 2 3 35